CCR3 antagonist 1
CCX354
Plozalizumab
Leronlimab
Bertilimumab
Mogamulizumab
Carlumab
Met-RANTES (human)
CKLF1-C19
DAPTA
Maceneolignan H
MK-0812
TAK-220
RS102895
Vicrivirocmaleate
Aplaviroc
CB-0821
YM-344031
AZ760
CCR8 antagonist 3